4-anilinoquinazoline EGFR :

Sallam Alagawani1, Vladislav Vasilyev2, Andrew H A Clayton3

  • 1Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Melbourne, VIC 3122, Australia.

PubMed
概括

在表皮生长因子受体 (EGFR) 抑制剂中的素替代影响电子特性和光谱特征,与药物的效力相关. 有效的抑制剂表现出更大的灵活性和明显的二极极时刻,这表明用于评估疗效的光学报告.